Johnson and Johnson has collaborated with Telangana-based Biological E Limited for the manufacturing of the COVID-19 vaccine.
"Johnson & Johnson is working with Biological E. Limited on the manufacturing of the Johnson COVID-19 vaccine. We believe Biological E. will be an important part of our global COVID-19 vaccine supply network, where multiple manufacturing sites are involved in the production of our vaccine across different facilities, sometimes in different countries and continents, before the vaccine can be distributed", states an official statement by Johnson and Johnson.
"We are working around the clock to develop and broadly activate our manufacturing capabilities to supply our COVID-19 vaccine worldwide and we appreciate the ongoing and extensive collaborations and partnerships we have with governments, health authorities and other companies to help end this pandemic", updated Johnson and Johnson statement.
In April, the US pharma firm told it is in discussion with the Indian government to soon begin bridging clinical trials in the country for its single-dose Covid-19 vaccine Janssen.
The firm's vaccine named, Janssen COVID-19 vaccine is presently approved for use in the United States, the European Union and other nations including Thailand and South Africa.
"At Johnson & Johnson, we remain fully focused on bringing a safe and effective Covid-19 vaccine to people around the world, if authorized for use by local health authorities. We are in discussions with the Government of India with the objective of starting a bridging clinical study of our Janssen Covid-19 vaccine candidate in India, subject to local regulatory approvals," a firm statement stated.
India presently has three official vaccines in use i.e. Covishied, Covaxin and Sputnik V.
